INVS
protein-codinginversin, the group of Ankyrin repeat domain containing
Gene summary
This gene encodes a protein containing multiple ankyrin domains and two IQ calmodulin-binding domains. The encoded protein may function in renal tubular development and function, and in left-right axis determination. This protein interacts with nephrocystin and infers a connection between primary cilia function and left-right axis determination. A similar protein in mice interacts with calmodulin. Mutations in this gene have been associated with nephronophthisis type 2. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, May 2012]
- NPHP2
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~202.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0011190
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0011190
Submitter: ClinGen
*INVS* was first reported in relation to autosomal recessive nephronophthisis-*INVS* in 2003 (Otto et al.; PMID: 12872123). At least 15 unique variants (missense, nonsense, frameshift) have been reported in 11 probands in 3 publications (PMIDs: 12872123, 19177160, 31706999). Evidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data. Variants in this gene segregated with disease in one Bedouin family with 10 segregations (Haider et al. 1998; PMID: 9792867). The mechanism for disease is biallelic loss of function. This gene-disease association is supported by animal models and an expression study (PMIDs: 9744276, 26615802, 15852005). In summary, there is definitive evidence to support the relationship between *INVS* and autosomal recessive nephronophthisis-*INVS*. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Cystic and Ciliopathy Expert Panel on the meeting date 2/24/21 (SOP Version 8). Data provided by the ClinGen Prenatal GCEP from June 11, 2025 secondary analysis Prenatal features have been seen as early as 14 weeks gestation. Most consistent and characteristic prenatal features include enlarged/echogenic kidneys with numerous small cysts. Other prenatal features observed are mega cisterna magna; vermis hypoplasia; cystic liver and pancreas; situs inversus totalis; ciliary dysgenesis; hydrops fetalis; oligohydramnios; and anhydramnios (PMIDs: 23713026, 24677454, 28749478, 31706999, 32335886, 37880672).
Inheritance Pattern: AR
Disease ID:MONDO:0011190
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0011190
Submitter: Natera
Inheritance Pattern: AR
Disease ID:MONDO:0011190
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0017842
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011190
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Gastrointestinal; Neurologic; Renal
Intervention: General
Rationale:
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to INVS variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014425.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 8 | 315 | 323 | |||
| missense | 1 | 462 | 25 | 488 | ||
| nonsense | 29 | 18 | 2 | 49 | ||
| start loss | 0 | |||||
| frameshift | 36 | 27 | 7 | 1 | 71 | |
| splice donor/acceptor (+/-2bp) | 2 | 20 | 5 | 27 | ||
| Total | 67 | 66 | 484 | 341 | 0 | 958 |
Highest pathogenic variant AF is 0.00009486701
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055240.2 | 16 | MANE Select | |
| Ensembl | ENSP00000262457.2 | 16 | MANE Select | |
| RefSeq | NP_001305310.1 | 14 | Standard | |
| RefSeq | NP_001305311.1 | 10 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| invs | Danio rerio | Structure: pronephric proximal convoluted tubule Quality: increased diameter abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Wnt signaling pathway - Homo sapiens (human)
- Wnt Signaling in Kidney Disease
- Wnt Signaling Pathway
Biological Process
- multicellular organism development
- Wnt signaling pathway
- negative regulation of canonical Wnt signaling pathway
Molecular Function
- protein binding
- calmodulin binding
Cellular Component
- nucleus
- cytoplasm
- spindle
- microtubule
- cilium
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000262457
- Coding exons
- 16
- Length
- 201745
- Individuals with no LoFs
- 125615
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 133
- Defined
- 125748
- p
- 0.000529
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.07 | 502 | 574 | 0.874 | 0.0000309 | 6960 |
| Missense (PolyPhen) | 131 | 181.79 | 0.72062 | 2250 | ||
| Synonymous | 0.649 | 204 | 216 | 0.944 | 0.0000117 | 2112 |
| Loss of Function | 2.02 | 35 | 50.5 | 0.693 | 0.00000293 | 581 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00031 | rare |
| Latino/Admixed American | 0.00058 | 0.00058 | rare |
| Ashkenazi Jewish | 0.00050 | 0.00050 | rare |
| East Asian | 0.00060 | 0.00060 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00062 | 0.00062 | rare |
| South Asian | 0.00052 | 0.00046 | rare |
| Other | 0.0013 | 0.0013 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Required for normal renal development and establishment of left-right axis. Probably acts as a molecular switch between different Wnt signaling pathways. Inhibits the canonical Wnt pathway by targeting cytoplasmic disheveled (DVL1) for degradation by the ubiquitin-proteasome. This suggests that it is required in renal development to oppose the repression of terminal differentiation of tubular epithelial cells by Wnt signaling. Involved in the organization of apical junctions in kidney cells together with NPHP1, NPHP4 and RPGRIP1L/NPHP8 (By similarity). Does not seem to be strictly required for ciliogenesis (By similarity). {ECO:0000250, ECO:0000269|PubMed:15852005, ECO:0000269|PubMed:18371931}.;
- Disease
- DISEASE: Nephronophthisis 2 (NPHP2) [MIM:602088]: An autosomal recessive disorder resulting in end-stage renal disease. It is characterized by early onset and rapid progression. Phenotypic manifestations include enlarged kidneys, chronic tubulo- interstitial nephritis, anemia, hyperkalemic metabolic acidosis. Some patients also display situs inversus. Pathologically, it differs from later-onset nephronophthisis by the absence of medullary cysts and thickened tubular basement membranes, and by the presence of cortical microcysts. {ECO:0000269|PubMed:12872123}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.215
Intolerance Scores
- LoFtool
- 0.912
- RVIS EVS
- -0.57
- RVIS percentile EVS
- 19.04
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.831
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |